Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Peritoneal Dialysis Fluid as a Source of Hepatitis Antigen

      , ,

      Nephron

      S. Karger AG

      Renal failure, Hepatitis, Peritoneal dialysis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          An epidemic of HB<sub>s</sub>Ag positive hepatitis involving the dialysis unit of the Seattle Veterans Administration Medical Center is described. 6 patients and 4 staff members were affected: there were four patient deaths. The source of HB<sub>s</sub>Ag was identified as a chronic in-center peritoneal dialysis patient in whom both serum and peritoneal fluid were persistently HB<sub>s</sub>Ag positive. Surveillance data documented heavy population exposure to HB<sub>s</sub>Ag at the time of this patient’s presence in the dialysis setting. We have subsequently identified 2 other patients with HB<sub>s</sub>Ag positive peritoneal effluent. Peritoneal dialysis of HB<sub>s</sub>Ag positive individuals represents a significant risk for the transmission of HB<sub>s</sub>Ag and clinical hepatitis.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1981
          1981
          03 December 2008
          : 29
          : 3-4
          : 107-109
          Affiliations
          Veterans Administration Medical Center, Seattle, Wash. USA.
          Article
          182324 Nephron 1981;29:107–109
          10.1159/000182324
          7329484
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 3
          Categories
          Original Paper

          Cardiovascular Medicine, Nephrology

          Peritoneal dialysis, Renal failure, Hepatitis

          Comments

          Comment on this article